Search Results 591-600 of 17121 for treatment resistant depression
... resistant to bortezomib (refractory). Ixazomib citrate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth ...
The purpose of the study is to determine the best dose of CC-486 (oral azacitidine) combined with pembrolizumab for the treatment of platinum-resistant ...
Clinical Trials · Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia · More about research at Mayo ...
Teen depression · Teen drug abuse · Nutrition and pain · Pain rehabilitation · Self-care approaches to treating pain · Treatment-resistant depression ...
Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory ...
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia · Share · Facebook · Twitter.
Division of Integrated Behavioral Health; Mayo Clinic Depression Center; Mayo Clinic John E. Herman Home and Treatment Facility; Mayo Clinic Psychiatric ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
The purpose of this study is to perform an in-depth review of pre-operative considerations and indications for spinal cord stimulation (SCS) for refractory ...
... Refractory Kidney Pain. Rochester, Minn. The purpose of this study is to examine patient reported outcomes including pain, quality of life, depression and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.